M & A Law Prof Blog

Editor: Brian JM Quinn
Boston College Law School

Friday, April 8, 2011

Sanofi completes Genzyme acquisition

Sanofi closed its acquisition of Genzyme today:

Sanofi said more than 237 million Genzyme shares were tendered in the transaction, representing 89.4 percent of outstanding shares. Sanofi then exercised a top-up option, resulting in ownership of more than 90 percent of Genzyme's shares.

Genzyme's CVRs started trading on April 4 under the ticker symbol "GCVRZ".  It opened at $2.20/right:





| Permalink

TrackBack URL for this entry:


Listed below are links to weblogs that reference Sanofi completes Genzyme acquisition:


Post a comment